Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Zenas BioPharma

Biotech & Life Sciences · Waltham, United States · Founded 2020 · IPO 2024 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$754M
Market cap · Apr/2026
Revenue
$10.0M
Latest reported FY

Investors

20 investors on Zenas BioPharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Quan Capital
Tellus BioVentures
Wellington Management
Fairmount Funds Management
Series B+ 16 investors entered at this stage
SR One
Rock Springs Capital
Superstring Capital
Enavate Sciences
Agent Capital
Pivotal Life Sciences
Xencor
Federated Hermes
NEA
Perceptive Advisors
Longitude Capital
Vivo Capital
ArrowMark Partners
Norwest Venture Partners
Delos Capital
Pivotal BioVenture Partners

Global footprint

Where Zenas BioPharma has talent and traffic

Web traffic by country
22K monthly visits
across markets
🇬🇧 United Kingdom64.1%
🇺🇸 United States23.2%
🇨🇦 Canada7.7%
🇯🇵 Japan3.6%
🇮🇱 Israel0.5%
Top 5 markets shown

See Zenas BioPharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo